VIRAMUNE XR Trademark

Trademark Overview

On Friday, February 19, 2010, a trademark application was filed for VIRAMUNE XR with the United States Patent and Trademark Office. The USPTO has given the VIRAMUNE XR trademark a serial number of 77939784. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, July 21, 2022. This trademark is owned by BOEHRINGER INGELHEIM PHARMACUETICALS, INC.. The VIRAMUNE XR trademark is filed in the Pharmaceutical Products category with the following description:

Antivirals; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of HIV-1 infection; therapeutic pharmaceutical for the treatment of HIV-1 infection
viramune xr

General Information

Serial Number77939784
Word MarkVIRAMUNE XR
Filing DateFriday, February 19, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, July 21, 2022
Registration Number4168351
Registration DateTuesday, July 3, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 20, 2010

Trademark Statements

Goods and ServicesAntivirals; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of HIV-1 infection; therapeutic pharmaceutical for the treatment of HIV-1 infection
Disclaimer with Predetermined Text"XR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 24, 2010
Primary Code005
First Use Anywhere DateThursday, April 7, 2011
First Use In Commerce DateThursday, April 7, 2011

Trademark Owner History

Party NameBOEHRINGER INGELHEIM PHARMACUETICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRIDGEFIELD, CT 06877
Party NameBOEHRINGER INGELHEIM PHARMACUETICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRIDGEFIELD, CT 06877
Party NameBOEHRINGER INGELHEIM PHARMACUETICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRIDGEFIELD, CT 06877

Trademark Events

Event DateEvent Description
Thursday, July 21, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, July 21, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, July 21, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, July 21, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 8, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, July 3, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, August 28, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, August 28, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 28, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, July 21, 2017TEAS SECTION 8 & 15 RECEIVED
Monday, July 3, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 3, 2012REGISTERED-PRINCIPAL REGISTER
Friday, June 1, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, May 31, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, May 29, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 8, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 8, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 18, 2012TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, December 9, 2011NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, December 9, 2011FINAL REFUSAL E-MAILED
Friday, December 9, 2011SU - FINAL REFUSAL - WRITTEN
Friday, November 18, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 17, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 17, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, October 30, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, October 30, 2011NON-FINAL ACTION E-MAILED
Sunday, October 30, 2011SU - NON-FINAL ACTION - WRITTEN
Monday, October 3, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 3, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 3, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 15, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 15, 2011NON-FINAL ACTION E-MAILED
Thursday, September 15, 2011SU - NON-FINAL ACTION - WRITTEN
Wednesday, August 10, 2011STATEMENT OF USE PROCESSING COMPLETE
Friday, August 5, 2011USE AMENDMENT FILED
Friday, August 5, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 5, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 5, 2011TEAS STATEMENT OF USE RECEIVED
Wednesday, October 6, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 5, 2010SOU EXTENSION 1 GRANTED
Tuesday, September 14, 2010SOU EXTENSION 1 FILED
Tuesday, October 5, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 14, 2010TEAS EXTENSION RECEIVED
Tuesday, September 14, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 20, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 20, 2010PUBLISHED FOR OPPOSITION
Saturday, June 12, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 10, 2010ASSIGNED TO LIE
Wednesday, May 26, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 24, 2010ASSIGNED TO EXAMINER
Wednesday, February 24, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 23, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

viramune pharmaceutical treatment infection preparations therapeutic infectious antivirals diseases